Isaac Lopez
Physician Assistant · McAllen, TXNPI 1649761297
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 387 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 387 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$959
- Lilly USA, LLC$884
- Astellas Pharma US Inc$573
- Amgen$370
- GSK$351
- plus $2K from 33 others
What the payments were for
- Food & beverage$6,66396%
- Education$2984%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $1,330 |
| Novo Nordisk | 59 | $959 |
| Lilly USA, LLC | 58 | $884 |
| Astellas Pharma US Inc | 20 | $573 |
| Amgen | 20 | $370 |
| GSK | 17 | $351 |
| Boehringer Ingelheim | 14 | $344 |
| AstraZeneca | 14 | $232 |
| Pfizer | 9 | $182 |
| Sumitomo Pharma America, Inc. | 7 | $168 |
| Johnson & Johnson | 7 | $153 |
| Bayer | 6 | $141 |
| Exact Sciences | 7 | $133 |
| Otsuka America Pharmaceutical, Inc. | 5 | $124 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $108 |
| Abbott | 5 | $92 |
| Viatris Specialty LLC | 1 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $81 |
| Philips North America LLC | 5 | $78 |
| Novartis | 4 | $78 |
| Dexcom, Inc. | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $53 |
| Phadia US Inc. | 2 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Baxter Healthcare | 1 | $29 |
| Lundbeck LLC | 1 | $27 |
| Averitas Pharma Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Genentech USA, Inc. | 2 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Acclarent, Inc | 1 | $17 |
| Merck | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$6,961 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 90 | $117,859 |
| MounjaroTirzepatide | 63 | $99,409 |
| JardianceEmpagliflozin | 37 | $49,659 |
| JanuviaSitagliptin Phosphate | 23 | $32,219 |
| LinzessLinaclotide | 39 | $25,990 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $24,965 |
| MyrbetriqMirabegron | 28 | $18,973 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $16,960 |
| EliquisApixaban | 15 | $14,721 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $13,231 |
| EntrestoSacubitril/Valsartan | 12 | $8,123 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 38 | $2,653 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,237 |
| Gabapentin | 120 | $1,695 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $1,603 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $959 | $117,85990 claims |
| Lilly USA, LLCMounjaro | $884 | $99,40963 claims |
| MerckJanuvia, Janumet | $17 | $57,18438 claims |
| Boehringer IngelheimJardiance | $344 | $49,65937 claims |
| AbbVieLinzess | $1,330 | $25,99039 claims |
| Astellas Pharma US IncMyrbetriq | $573 | $18,97328 claims |
| PfizerEliquis | $182 | $14,72115 claims |
| GSKTrelegy Ellipta | $351 | $13,23121 claims |
| NovartisEntresto | $78 | $8,12312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in McAllen
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.